Cuming & Gillespie LLP continue to proceed with the Canadian National Class Action with respect to the Vioxx claims.The Vioxx claims within the U.S. only have been resolved for the sum of $4,850,000.00 dollars pursuant to an agreement between Merck & Co. Inc and a six member negotiating committee on behalf of all U.S. Plaintiffs. The details of the U.S. settlement are available online at claim has not resolved and will be proceeding to a certification hearing in 2008.